ProbGen Biotech is a global leader in high-performance diagnostic screening. We design, manufacture, and validate molecular diagnostics assays across qPCR, NGS, Forensics, and ELISA platforms.
High-efficiency extraction kits and automated systems that ensure pure, consistent, and reliable recovery of DNA and RNA. Built for seamless workflow integration, they provide the ideal foundation for downstream molecular applications including PCR, sequencing, and clinical testing.
ProbGen Biotech India Private Limited is positioned in the supplied materials as an Indian manufacturer focused on PCR-based molecular diagnostic kits. Its activities cover design, development, manufacturing and commercialization of molecular diagnostic kits, PCR enzymes and reagents.
The company combines in-house molecular-development capability with a product strategy spanning infectious disease diagnostics, next-generation sequencing, oncology, human identification, ELISA and rapid diagnostics.
Revolutionizing biotechnology with next-generation technology for precise and reliable outcomes, while advancing access to modern genomics and molecular-diagnostic tools in India.
Build a strong Indian molecular-diagnostics platform with an expanding portfolio, continuous R&D and reach across India and international markets. The company’s stated tagline is "One Step Ahead".
| Brand | Focus |
|---|---|
| GENPLEX™ | Singleplex and multiplex RT-PCR molecular clinical diagnostic kits |
| IVDNGS™ | NGS and library-preparation based in-vitro diagnostic solutions |
| GENONCO™ | Oncology-focused molecular diagnostic kits |
| GENHUMAN ID™ | Human identification and forensic DNA analysis kits |
| GENLISA™ | ELISA-based diagnostic solutions |
| GENRAPI™ | Rapid diagnostic solutions |
The supplied presentation describes an experienced R&D team with Ph.D. and post-doctoral researchers and expertise in molecular biology, genetic engineering, biotechnology, NGS and infectious diseases. The company emphasizes the ability to develop new diagnostic parameters and customized diagnostic solutions.
The June 2026 company presentation lists the following licences, certificates and registrations. They are reproduced here as stated in the supplied source and should be checked against current certificates before external publication.
ProbGen Biotech’s stated business objective is to design, develop and manufacture advanced RT-PCR-based clinical molecular diagnostic solutions for India and selected international markets. The presentation also states relationships/reach across hospitals and laboratories in Tier-1, Tier-2 and Tier-3 locations in India.
Founder, Chairman & CEO
Founder, Chairman & CEO
"One Step Ahead"ProbGen Biotech is committed to continuous research, product innovation and the development of precise, reliable and accessible molecular diagnostic solutions for healthcare and laboratory partners.
ProbGen Biotech India Pvt. Ltd.
P. No. 03, Laxmi Industrial Park, Sector 08, Derabassi-Barwala Road, Punjab 140507, India
Landline: 01762 378400 | Phone: +91 88609 82424 / +91 98737 11223
Email: info@probgenbiotech.com
Website: www.probgenbiotech.com
Explore our innovative, cutting-edge solutions in molecular diagnostics.
High-sensitivity multiplex and singleplex molecular assays.
High-throughput real-time PCR thermal cycling platform.
High-precision multi-target diagnostic molecular assay kit.
High-sensitivity assay for Hepatitis B Surface Antigen detection.
Quantitative RT-PCR assay for Hepatitis B Virus (HBV) viral load monitoring.
Qualitative detection of Hepatitis C Virus antibodies using double-antigen sandwich ELISA.
Quantitative detection of Hepatitis C Virus RNA in plasma and serum with wide dynamic range.
Dual quantitative detection of HIV-1 & HIV-2 RNA for early diagnosis and treatment monitoring.
Dual Ag/Ab detection of HIV-1 p24 antigen & antibodies using 4th generation ELISA platform.
Qualitative differential detection of high-risk HPV genotypes 16 & 18 in cervical and vaginal samples.
28-target multiplex PCR for rapid CNS pathogen detection — bacteria, viruses, fungi & AMR genes from CSF.
AI-Powered Precision Gut & Vaginal Microbiome profiling. Simultaneous detection of multiple targets with software-based reporting.
Multiplex detection of HBV, HCV, HIV 1&2, and RNaseP in a dual-tube system validated with WHO standards.
44-target multiplex real-time PCR for rapid bloodstream pathogen & drug resistance detection from Whole Blood.
22-target multiplex PCR for simultaneous qualitative detection of bacteria, viruses, and parasites from stool.
47-target multiplex real-time PCR for simultaneous detection of respiratory viruses, bacteria, atypical bacteria & AMR genes.
We build diagnostic solutions with highly optimized bio-chemical standards, ensuring absolute sensitivity, specificity, and high-throughput reliability.
Quantitative multiplex and singleplex molecular assays using advanced target-specific primers and probes. Optimized for rapid diagnosis, high thermal-cycle precision, and broad dynamic linear range.
Deep-coverage genetic sequencing panels for somatic cancer mutation profiling, non-invasive paternal screening, and whole-exome biological mapping.
Immunoassay kits using validated antibody-antigen enzymes, optimized for large-scale clinical screens of bloodborne viral agents and tropical fever antibodies.
High-resolution Short Tandem Repeat (STR) genetic assays tailored for forensic human identification, parentage tests, and complex bone specimen mapping.
Our research and clinical testing modules are backed by standard accreditations, ensuring all data outputs are legally and medically compliant.
Ensuring absolute safety, clinical accuracy, and laboratory compliance in line with College of American Pathologists standards.
Fully compliant with international quality management regulations specific to medical devices and diagnostic testing laboratories.
Sample preparation is handled via automated extraction pipelines, eliminating potential human error or environmental contamination.
All clinical diagnostic kits are optimized for modern Real-Time thermal cyclers, ensuring absolute amplification reliability.
Follow the chronological path of clinical specimens from point-of-collection to final bioinformatics interpretation.
Clinical specimens (e.g. swab, blood, stool) are collected using molecular stabilization buffer kits.
Automated isolation of high-purity nucleic acids, stripping molecular inhibitors.
Real-Time amplification or genetic sequencing using validated ProbGen primer panels.
Biomedical algorithms synthesize Ct values into clear, actionable clinical dashboards.
Select a dynamic biological testing profile for patients, or an automated molecular reporting pipeline subscription for diagnostic laboratories.
Baseline biochemical mapping of gut metabolic integrity.
Complete pathogenetic screening for molecular dominance.
Deep Next-Gen Metagenomic sequencing maps.
Ideal for local screening hubs managing minor workflows.
Designed for certified clinical testing labs.
Unlimited processing power for diagnostic networks.
